Our Research Publications

Updated November 2023

Title Authors Year Journal Link to Article Intended Audience Sort ascending Purpose
Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectors Yazer MH, Shaz B, Seheult JN, Apelseth TO, de Korte D, Devin G, Devine D, Doncaster C, Field S, Flanagan P, Huet J, Mendrone Jr A, O’Brien C, Pink J, Rashleigh M, Shinar E, Takanashi M, Tian E, Tiberghien P, van den Berg K, Schmitt C 2020 Vox Sang Blood operators Benchmarking and standard setting
Research partnerships between blood services and public health authorities: An international, cross-sectional survey Lewin A, Osiowy C, Erikstrup C, Custer B, Renaud C, Tiberghien P, Russell A, Lieshout-Krikke R, O'Brien SF, the Surveillance Risk Assessment Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party 2022 Vox Sang Blood operators Benchmarking and standard setting
Development of a quality monitoring program for platelet components: a report of the first four years' experience at Canadian Blood Services Levin E, Jenkins C, Culibrk B, Gyongyossy-Issa MIC, Serrano K, Devine DV 2012 Transfusion Blood operators New or improved product or process
Frequency and risk factors for donor reactions in an anonymous blood donor survey Goldman M, Osmond L, Yi QL, Cameron-Choi K, O'Brien SF 2012 Transfusion Blood operators Other
Implementation and public acceptability: lessons from food irradiation and how they might apply to pathogen reduction in blood products Heddle NM, Lane SJ, Sholapur N, Arnold E, Newbold B, Eyles J, Webert KE 2014 Vox Sang Blood operators Other
Seroprevalence of Babesia microti infection in Canadian blood donors O'Brien SF, Delage G, Scalia V, Lindsay R, Bernier F, Dubuc S, Germain M, Pilot G, Yi Q-L, Fearon MA 2016 Transfusion Blood operators New or improved product or process
Vox Sanguinis international forum on platelet cryopreservation: summary Cohn CS, Dumont LJ, Lozano M, Marks D, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker J, Bohonek M, Sailliol A, Martinaud C, Poglod R, Antoniewicz-Papis J, Lachert E, Pun P, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M 2017 Vox Sang Blood operators New or improved product or process
Development and evaluation of stem cell collection procedure diagrams to support the education and recruitment of committed stem cell donors Fingrut W, Cuperfain AB, Chan SWS, Ptak E, Kahlon M, Dhaliwal J, Naidu A, Wang YG, Baribeau O, Mahmoudi T, Lee A, Suppiah R, Luo OD, Green M, Weiss JT, Mercer D, Elmoazzen H, Petraszko T, Allan D 2020 Vox Sang Blood operators New or improved product or process
International Forum on Walking Blood Bank Programmes: Responses Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Nadarajan VS, Dunbar N 2021 Vox Sang Blood operators New or improved product or process
Impact of product platelet count reduction on platelet demand in Canada Devine DV 2022 Transfusion Blood operators Benchmarking and standard setting
Aggregates in platelet concentrates van der Meer PF, Dumont LJ, Lozano M, Bondar N, Wong J, Ismay S, Pink J, Nussbaumer W, Coene J, Feys HB, Compernolle V, Devine DV, Howe D, Lin CK, Sun J, Ringwald J, Strasser EF, Eckstein R, Seltsam A, Perseghin P, Proserpio P, Wakamoto S, Akino M, Takamoto S, Tadokoro K, Teo D, Shu PH, Chua SS, Jimenez-Marco T, Lozano M, Cid J, Castro E, Munoz I, Gulliksson H, Sandgren P, Thomas S, Petrik J, McColl K, Kamel H, Dugger J, Sweeney JD, Gorlin JB, Sutor LJ, Heath D, Sayers MH 2015 Vox Sang Blood operators Benchmarking and standard setting
Deja-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Hema-Quebec Blake JT, Hardy M, Delage G, Myhal G 2013 Transfusion Blood operators New or improved product or process
Iron status in Canadian Blood Services Donors Goldman M 2014 Blood.ca website Blood operators Clinical research
Pathogen Inactivation Technologies: The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk Devine DV, Schubert P 2016 Hematol Oncol Clin North Am Blood operators Other
Quality of frozen transfusable plasma prepared from whole blood donations in Canada: An update Sheffield WP, Bhakta V, Talbot K, Pryzdial ELG, Jenkins C 2013 Transfus Apher Sci Blood operators Benchmarking and standard setting
Buffy coat platelets coming to America: Are we ready? Gammon RR, Devine D, Katz LM, Quinley E, Wu Y, Rowe K, Razatos A, Min K, Reichenberg S, Smith R 2021 Transfusion Blood operators New or improved product or process
Trans people and blood donation Goldman M, Butler-Foster T, Lapierre D, O'Brien SF, Devor A 2020 Transfusion Blood operators New or improved product or process
ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort Woo H 2022 Blood.ca website Blood operators MSM research
Use of selective phenotyping and genotyping to identify rare blood donors in Canada Tordon B, Montemayor C, Clarke G, O'Brien SF, Goldman M 2023 Vox Sang Blood operators Clinical research
Biofilm formation by Staphylococcus capitis strains isolated from contaminated platelet concentrates Greco-Stewart VS, Ali H, Kumaran D, Kalab M, Rood IG, de Korte D, Ramirez-Arcos S 2013 J Med Microbiol Blood operators Basic research
Storage duration and other measures of quality of red blood cells for transfusion Spinella PC, Acker J 2015 JAMA Blood operators Other
Implementation of pathogen inactivation technology: How to make the best decisions? Devine DV 2017 Transfusion Blood operators New or improved product or process
Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture Greco-Stewart VS, Brown EE, Parr C, Kalab M, Jacobs MR, Yomtovian RA, Ramirez-Arcos SM 2012 Vox Sang Blood operators Basic research
Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry?Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D 2017 Vox Sang Blood operators Clinical research
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee C-K, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C 2021 Vox Sang Blood operators New or improved product or process
International Forum on Walking Blood Bank Programmes: Summary Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Sekaran Nadarajan V, Dunbar N 2021 Vox Sang Blood operators Benchmarking and standard setting
Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis Allan DS, Green M, Morris G, Weiss J, Dibdin N, Mercer D, Seftel M 2022 Vox Sang Blood operators Clinical research
Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking Allan DS, Scrivens N, Lawless T, Mostert K, Oppenheimer L, Walker M, Petraszko T, Elmoazzen H 2015 Transfusion Blood operators Other
Mitigation of the threat posed to transfusion by donors traveling to Zika-affected areas: a Canadian risk-based approach Germain M, Delage G, O'Brien SF, Grégoire Y, Fearon M, Devine D 2017 Transfusion Blood operators Clinical research
Alternative methods of blood donor skin disinfection Ramirez-Arcos S, Taha M, Kou Y, Goldman M 2017 Blood.ca website Blood operators New or improved product or process
Biofilm-forming skin microflora bacteria are resistant to the bactericidal action of disinfectants used during blood donation Taha M, Kalab M, Yi QL, Landry C, Greco-Stewart V, Brassinga AK, Sifri CD, Ramirez-Arcos S 2014 Transfusion Blood operators New or improved product or process
Determining recruiting strategies for an adult stem cell registry Blake JT, McTaggart K, Killeen D 2016 Oper Res Health Care Blood operators New or improved product or process
Donor attention to reading materials O'Brien SF, Osmond L, Choquet K, Yi QL, Goldman M 2015 Vox Sang Blood operators Other
Evaluation of the BacT/ALERT 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services Mastronardi C, Perkins H, Derksen P, denAdmirant M, Ramirez-Arcos S 2010 Clin Chem Lab Med Blood operators New or improved product or process
Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals O'Brien SF, Uzicanin S, Choquet K, Yi QL, Fan W, Goldman M 2013 Blood Transfus Blood operators New or improved product or process
Proceedings of a Consensus Conference: Risk-Based Decision Making for Blood Safety Leach Bennett J, Blajchman MA, Delage G, Fearon M, Devine D 2011 Transfus Med Rev Blood operators Other
SARS in Canada: Lessons learned for the blood operator Devine DV 2020 Transfus Med Blood operators Other
Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality Hadjesfandiari N, Khorshidfar M, Devine DV 2021 Int J Mol Sci Blood operators New or improved product or process
Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic Drews SJ, O’Brien SF 2022 Viruses Blood operators New or improved product or process
Development of standard definitions for surveillance of complications related to blood donation Goldman M, Land K, Robillard P, Wiersum-Osselton J 2016 Vox Sang Blood operators Benchmarking and standard setting
From Development to Implementation: Adjusting the Hematocrit of Deglycerolized Red Cell Concentrates to Meet Regulatory Standards Turner T, Hansen A, Kurach J, Acker JP 2017 Transfus Med Hemother Blood operators Benchmarking and standard setting
Vox Sanguinis international forum on provision of granulocytes for transfusion and their clinical use: summary Morton S, Stanworth S, Lozano M, Harrison S, Hong F, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner J, Yokoyama A, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze T, Bux J, Pierelli L, Ballester C, Netelenbos T, West K, Conry-Cantilena C, Eder A, Haley N, Yazer M, Triulzi D 2017 Vox Sang Blood operators Clinical research
Bacterial contamination in platelet concentrates Pietersz RNI, Reesink HW, Panzer S, Oknaian S, Kuperman S, Gabriel C, Rapaille A, Lambermont M, Deneys V, Sondag D, Rami­rez-Arcos S, Goldman M, Delage G, Bernier F, Germain M, Vuk T, Georgsen J, Morel P, Naegelen C, Bardiaux L, Cazenave JP, Dreier J, Vollmer T, Knabbe C, Seifried E, Hourfar K, Lin CK, Spreafico M, Raffaele L, Berzuini A, Prati D, Satake M, de Korte D, van der Meer PF, Kerkhoffs JL, Blanco L, Kjeldsen-Kragh J, Svard-Nilsson AM, McDonald CP, Symonds I, Moule R, Brailsford S, Yomtovian R, Jacobs MR 2014 Vox Sang Blood operators Benchmarking and standard setting
Pathogen reduction technologies: The pros and cons for platelet transfusion Magron A, Laugier J, Provost P, Boilard E 2018 Platelets Blood operators Basic research
Using simulation for strategic blood supply chain design in the Canadian prairies Blake J, McTaggart K 2016 Proceedings of the 6th International Conference on SIMULTECH Blood operators New or improved product or process
An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers Lewin A, Drews SJ, Lieshout-Krikke R, Erikstrup C, Saeed S, Fady H, Uzicanin S, Custer B, O’Brien SF, the Surveillance Risk Assessment Policy tVS-gotI, Transfusion Transmitted Infectious Diseases Working Party 2021 Vox Sang Blood operators Benchmarking and standard setting
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study Cho JH, Rajbhandary S, van Buren NL, Fung MK, Al-Ghafry M, Fridey JL, Dy BA, Ziman A, Schreiber GB, Gammon RR, Reik R, Stubbs JR, van Buskirk CM, Kamel H, Townsend MJ, Zeller MP, Gottschall JL 2021 Transfusion Blood operators Benchmarking and standard setting
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men Aubé E, Lewin A, O'Brien SF, Grégoire Y, Pillonel J, Steele WR, Custer B, Davison KL, Germain M, Seed CR, Camirand Lemyre F, the Surveillance RA, Policy Subgroup of the ISBT Transfusion Transmitted Infectious Diseases Working Party 2022 Vox Sang Blood operators MSM research
Alternatives in blood operations when choosing non-DEHP bags van der Meer PF, Devine DV, on behalf of the BEST Collaborative 2017 Vox Sang Blood operators New or improved product or process
Determining staffing requirements for blood donor clinics: the Canadian Blood Services experience Blake JT, Shimla S 2014 Transfusion Blood operators New or improved product or process